Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Well plate

    With Foundation Support, New Drugs Are Moving Closer to Market

    One of the most vexing aspects of Parkinson’s disease — to patients, clinicians and researchers — is its tremendous variability.
    Learn more
  • Fox Insight from Home.jpg

    Fox Insight Brings Research to You, at Home

    When it comes to understanding Parkinson’s disease (PD) and prioritizing patient needs, it’s vital to integrate the perspectives of people living with the disease.
    Learn more
  • following PD pipeline.jpg

    Following the Parkinson’s Pipeline Toward Cures

    The Michael J. Fox Foundation (MJFF) is tracking the progress surrounding therapies in our priority programs: alpha-synuclein, LRRK and GBA.
    Learn more
  • LRRK2 Cells

    LRRK2 Therapies: Back from the Brink

    Several recently published papers explain the efforts from MJFF and our partners to advance LRRK2 therapies.
    Learn more
  • Default content image

    Research Perspective: Reflecting on the Latest FDA Approvals in Parkinson’s and the Promise Ahead

    Staff scientists share their perspectives on the latest FDA approval of Parkinson's drugs and the future of therapeutic development.
    Learn more
  • Online Communities Help Caregivers Find Support, Save Time

    The Michael J. Fox Foundation Kicks Off New Online Event Series on Parkinson’s R&D

    Our new series of digital events, the Parkinson’s Disease Therapeutics Webinars, are free and feature presentations and discussions from leaders in Parkinson’s research and therapeutic development.
    Learn more
  • Kynmobi films and foils

    Supported by Early MJFF Investments, New Parkinson’s “Off” Therapy Receives Regulatory Approval

    The FDA recently approved a new Parkinson's medication — the second this year and the second MJFF funding made possible — for as-needed treatment of “off” time, when symptoms return between…
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.